EMEA-001491-PIP01-13

Key facts

Active substance
Cyclic pyranopterin monophosphate (monohydrobromide dihydrate)
Therapeutic area
Other
Decision number
P/0071/2014
PIP number
EMEA-001491-PIP01-13
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Treatment of molybdenum cofactor deficiency type A
Route(s) of administration
Intravenous use
Contact for public enquiries
Origin Biosciences Inc.

Tel. +33141318661
E-mail: Merlay-barbin@voisinconsulting.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating